BIOVIC.BBiovica International ABBIOVIC.B info
$0.24info-2.94%24h
Global rank
Market cap$18.62M
Change 7d-4.00%
YTD Performance2.33%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Biovica International AB (BIOVIC.B) Stock Overview

    Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum TKa, a biomarker assay that measures thymidine kinase activity, which reflects tumor cell proliferation. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.

    BIOVIC.B Stock Information

    Symbol
    BIOVIC.B
    Address
    Dag HammarskjOelds vAeg 54BUppsala, 752 37Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://www.biovica.com
    Country
    πŸ‡ΈπŸ‡ͺ Sweden
    Phone Number
    46 1 84 44 48 30

    Biovica International AB (BIOVIC.B) Price Chart

    -
    Value:-

    Biovica International AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.23937978872920165
    N/A
    Market Cap
    $18.62M
    N/A
    Shares Outstanding
    77.78M
    N/A
    Employees
    37.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org